RPL10 and leukemia: Even though we did not have available an internally controlled model for the study of the effects of the mutation in leukemia cells (such as a knock-in mutant in a T-ALL cell line), we decided to observe some specific phenotypic features of patient’s cells bearing the RPL10 Q123R mutation, compared to other patients of the same cohort.